P
Über
Pablo Valenzuela has over four decades of experience in investment and business development within the biotechnology industry. He has developed numerous cutting-edge medical technologies, including the hepatitis B vaccine. He co-founded Chiron Corporation in 1982, a pioneer in genetic engineering. In 2005, Novartis acquired his company for $8.9 billion.
Schwerpunkte
BioTech
Verifizierte Kontakte & Outreach Agenten
Direktes E-Mail-Muster
KI Outreach Agenten Pitch Writer
Erstelle personalisierte Anschreiben basierend auf den genauen Investitionskriterien...